Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.7 |
mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |